MeiraGTx Holdings MGTX
NASDAQ MGTX
$13.89 -0.08 (-0.57%)
As of: Sep 4, 2026 · 3:59 PM EDT

MeiraGTx Holdings (MGTX) Change in Account Payables (2017 - 2025)

MeiraGTx Holdings' (MGTX) quarterly Change in Account Payables came in at -$10.0 million in Q4 2025, down 202.83% YoY from $9.7 million in Q4 2024, and down 1742.08% on a QoQ basis from $606000.0 in Q3 2025.

Analysis

MeiraGTx Holdings (MGTX) Change in Account Payables (2017 - 2025) Analysis & Trends

MeiraGTx Holdings (MGTX) has 9 years of Change in Account Payables data on file, last reported at -$10.0 million in Q4 2025.

  • Quarterly Change in Account Payables fell 202.83% year-over-year to -$10.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$12.3 million (down 214.67% YoY) and the FY2025 annual result came in at -$12.3 million, down 214.67% from the prior year.
  • Change in Account Payables fell to -$10.0 million in Q4 2025, from $606000.0 in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $14.6 million in Q1 2023 to a low of -$10.0 million in Q4 2025.
  • A 5-year average of $891950.0 and a median of $539000.0 in 2024 frame the typical range for Change in Account Payables.
  • Annual changes were most pronounced in 2021 — Change in Account Payables jumped 770.88% — and 2023, when it slumped 256.01%.
  • Tracing MGTX's Change in Account Payables over 5 years: stood at $9.4 million in 2021, then slumped by 151.76% to -$4.9 million in 2022, then soared by 37.37% to -$3.1 million in 2023, then fell by 7.28% to -$3.3 million in 2024, then tumbled by 202.83% to -$10.0 million in 2025.
  • The last three Change in Account Payables figures came in at -$10.0 million (Q4 2025), $606000.0 (Q3 2025), and $93000.0 (Q2 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -66.70 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -8.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 5.03 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 37.53 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 MeiraGTx Holdings 1.27 Bn 1.13 Bn 315.67 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -9.95 Mn
Sep 30, 2025 606,000.00
Jun 30, 2025 93,000.00
Mar 31, 2025 -3.06 Mn
Dec 31, 2024 -3.29 Mn
Sep 30, 2024 8.35 Mn
Jun 30, 2024 472,000.00
Mar 31, 2024 5.20 Mn
Dec 31, 2023 -3.06 Mn
Sep 30, 2023 -7.68 Mn
Jun 30, 2023 -1.57 Mn
Mar 31, 2023 14.64 Mn
Dec 31, 2022 -4.89 Mn
Sep 30, 2022 4.92 Mn
Jun 30, 2022 -903,000.00
Mar 31, 2022 4.61 Mn
Dec 31, 2021 9.45 Mn
Sep 30, 2021 1.38 Mn
Jun 30, 2021 926,000.00
Mar 31, 2021 1.59 Mn